13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Exhibit 175: Inclusions checklist
- Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
- Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
- Exhibit 178: Research methodology
- Exhibit 179: Validation techniques employed for market sizing
- Exhibit 180: Information sources
13.5 List of abbreviations
- Exhibit 181: List of abbreviations
Exhibit:
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on Global flow cytometer market 2017 - 2021 ($ million)
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibit 46: Market opportunity by Product ($ million)
Exhibit 47: Chart on End-user - Market share 2022-2027 (%)
Exhibit 48: Data Table on End-user - Market share 2022-2027 (%)
Exhibit 49: Chart on Comparison by End-user
Exhibit 50: Data Table on Comparison by End-user
Exhibit 51: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibit 55: Chart on Health and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Health and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Market opportunity by End-user ($ million)
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 105: Market opportunity By Geographical Landscape ($ million)
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
Exhibit 108: Overview on factors of disruption
Exhibit 109: Impact of key risks on business
Exhibit 110: Vendors covered
Exhibit 111: Matrix on vendor position and classification
Exhibit 112: Agilent Technologies Inc. - Overview
Exhibit 113: Agilent Technologies Inc. - Business segments
Exhibit 114: Agilent Technologies Inc. - Key news
Exhibit 115: Agilent Technologies Inc. - Key offerings
Exhibit 116: Agilent Technologies Inc. - Segment focus
Exhibit 117: Amphasys AG - Overview
Exhibit 118: Amphasys AG - Product/Service
Exhibit 119: Amphasys AG - Key offerings
Exhibit 120: Apogee Flow Systems Ltd. - Overview
Exhibit 121: Apogee Flow Systems Ltd. - Product/Service
Exhibit 122: Apogee Flow Systems Ltd. - Key offerings
Exhibit 123: Becton Dickinson and Co. - Overview
Exhibit 124: Becton Dickinson and Co. - Business segments
Exhibit 125: Becton Dickinson and Co. - Key news
Exhibit 126: Becton Dickinson and Co. - Key offerings
Exhibit 127: Becton Dickinson and Co. - Segment focus
Exhibit 128: Bio Rad Laboratories Inc. - Overview
Exhibit 129: Bio Rad Laboratories Inc. - Business segments
Exhibit 130: Bio Rad Laboratories Inc. - Key news
Exhibit 131: Bio Rad Laboratories Inc. - Key offerings
Exhibit 132: Bio Rad Laboratories Inc. - Segment focus
Exhibit 133: Cytek Biosciences Inc. - Overview
Exhibit 134: Cytek Biosciences Inc. - Product/Service
Exhibit 135: Cytek Biosciences Inc. - Key offerings
Exhibit 136: Danaher Corp. - Overview
Exhibit 137: Danaher Corp. - Business segments
Exhibit 138: Danaher Corp. - Key news
Exhibit 139: Danaher Corp. - Key offerings
Exhibit 140: Danaher Corp. - Segment focus
Exhibit 141: DiaSorin SpA - Overview
Exhibit 142: DiaSorin SpA - Business segments
Exhibit 143: DiaSorin SpA - Key news
Exhibit 144: DiaSorin SpA - Key offerings
Exhibit 145: DiaSorin SpA - Segment focus
Exhibit 146: Enzo Biochem Inc. - Overview
Exhibit 147: Enzo Biochem Inc. - Product/Service
Exhibit 148: Enzo Biochem Inc. - Key offerings
Exhibit 149: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 150: Miltenyi Biotec B.V. and Co. KG - Product/Service
Exhibit 151: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibit 152: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibit 153: Sartorius AG - Overview
Exhibit 154: Sartorius AG - Business segments
Exhibit 155: Sartorius AG - Key news
Exhibit 156: Sartorius AG - Key offerings
Exhibit 157: Sartorius AG - Segment focus
Exhibit 158: Sony Group Corp. - Overview
Exhibit 159: Sony Group Corp. - Business segments
Exhibit 160: Sony Group Corp. - Key news
Exhibit 161: Sony Group Corp. - Key offerings
Exhibit 162: Sony Group Corp. - Segment focus
Exhibit 163: Stratedigm Inc. - Overview
Exhibit 164: Stratedigm Inc. - Product/Service
Exhibit 165: Stratedigm Inc. - Key offerings
Exhibit 166: Sysmex Corp. - Overview
Exhibit 167: Sysmex Corp. - Business segments
Exhibit 168: Sysmex Corp. - Key offerings
Exhibit 169: Sysmex Corp. - Segment focus
Exhibit 170: Thermo Fisher Scientific Inc. - Overview
Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
Exhibit 172: Thermo Fisher Scientific Inc. - Key news
Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
Exhibit 177: Currency conversion rates for US$
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
Exhibit 181: List of abbreviations